Rodriguez Ruiz Me
0000-0002-9765-2499
Clínica Universidad de Navarra
4 papers found
Refreshing results…
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Missing publications? Search for publications with a matching author name.